Oxaliplatin-induced peripheral neuropathy How to create a barrier?

被引：2
|
作者：
Taib, Sonia [1 ]
Durand, Juliette [1 ]
Brunet, Isabelle [1 ]
机构：
[1] Coll France, CNRS UMR 7241, Inserm U1050, CIRB, 11 Pl Marcelin Berthelot, F-75005 Paris, France
来源：
M S-MEDECINE SCIENCES | 2020年 / 36卷
关键词：
D O I：
10.1051/medsci/2020191
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 37
页数：5
相关论文
共 50 条
  • [31] Further study on the involvement of oxalate in the oxaliplatin-induced peripheral neuropathy in rats
    Kawashiri, Takehiro
    Egashira, Nobuaki
    Sakurai, Mariko
    Yano, Takahisa
    Ikesue, Hiroaki
    Oishi, Ryozo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 173P - 173P
  • [32] Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
    Yoshida, Naohisa
    Hosokawa, Toyoshi
    Ishikawa, Takeshi
    Yagi, Nobuaki
    Kokura, Satoshi
    Naito, Yuji
    Nakanishi, Masayoshi
    Kokuba, Yukihito
    Otsuji, Eigo
    Kuroboshi, Haruo
    Taniwaki, Masafumi
    Taguchi, Tetsuya
    Hosoi, Hajime
    Nakamura, Terukazu
    Miki, Tsuneharu
    JOURNAL OF ONCOLOGY, 2013, 2013
  • [33] Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study
    Yokoyama, Satoshi
    Nakagawa, Chihiro
    Hosomi, Kouichi
    SUPPORTIVE CARE IN CANCER, 2022, 30 (02) : 1765 - 1773
  • [34] Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
    Nao Shigematsu
    Takehiro Kawashiri
    Daisuke Kobayashi
    Shiori Shimizu
    Keisuke Mine
    Shiori Hiromoto
    Mayako Uchida
    Nobuaki Egashira
    Takao Shimazoe
    Scientific Reports, 10
  • [35] Symptom concerns and QOL in patients with oxaliplatin-induced peripheral neuropathy.
    Sun, Virginia
    Ferrell, Betty
    Otis-Green, Shirley
    Shibata, Stephen
    Juarez, Gloria
    Choi, Kyong
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 509 - 510
  • [36] Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population
    Zribi, Aref
    Ben Nasr, Sonia
    Hamdi, Syrine
    Ayari, Jihen
    Fendri, Sana
    Balti, Mehdi
    Haddaoui, Abderrazek
    PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [37] Efficacy of Goshajinkigan for prophylaxis against oxaliplatin-induced peripheral neuropathy.
    Kono, Toru
    Suzuki, Yasuyuki
    Mizuno, Keita
    Miyagi, Chika
    Omiya, Yuji
    Sekine, Hitomi
    Mizuhara, Yasuharu
    Miyano, Kanako
    Kase, Yoshio
    Uezono, Yasuhito
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [38] Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
    Warncke, Urszula O.
    Toma, Wisam
    Meade, Julie A.
    Park, Abigail J.
    Thompson, Danielle C.
    Caillaud, Martial
    Bigbee, John W.
    Bryant, Camron D.
    Damaj, M. Imad
    FRONTIERS IN PAIN RESEARCH, 2021, 2
  • [39] Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study
    Satoshi Yokoyama
    Chihiro Nakagawa
    Kouichi Hosomi
    Supportive Care in Cancer, 2022, 30 : 1765 - 1773
  • [40] Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy
    Delmotte, Jean-Baptiste
    Tutakhail, Abdulkarim
    Abdallah, Kahina
    Reach, Pauline
    D'Ussel, Marguerite
    Deplanque, Gad
    Beaussier, Helene
    Coudore, Francois
    NEUROLOGY RESEARCH INTERNATIONAL, 2018, 2018
12345